Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2004, for Anthem, Inc. (now Elevance Health). Anthem is a leading health benefits company and an independent licensee of the Blue Cross Blue Shield Association, operating in Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Maine, Colorado, Nevada, and Virginia. As of June 30, 2004, the company served approximately 12.6 million members.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2004 | Six Months Ended June 30, 2003 |
|---|---|---|
| Total Operating Revenue | $9,000.2 million | $8,075.1 million |
| Net Income | $533.5 million | $369.0 million |
| Diluted Earnings Per Share | $3.74 | $2.61 |
| Cash Provided by Operating Activities | $273.1 million | $394.2 million |
| Total Assets | $13,658.5 million | $13,438.6 million |
| Long-Term Debt | $1,664.6 million | $1,662.8 million |
| Cash and Cash Equivalents | $1,090.4 million | $464.5 million |
| Benefit Expense Ratio | 82.0% | 81.5% |
| Administrative Expense Ratio | 17.5% | 18.5% |
Material Changes vs. Prior Period
- Revenue Growth: Total operating revenue increased 11% to $9.0 billion, driven by an 11% increase in premiums and a 15% increase in administrative fees. Premium growth was fueled by rate increases and higher membership in Small Group and Individual segments.
- Profitability: Net income surged 45% to $533.5 million. This was aided by a significant improvement in net realized gains on investments ($34.5 million in 2004 vs. $2.5 million in 2003) and a $44.8 million tax benefit from Indiana legislation changes.
- Cost Trends: Benefit expense increased 12% to $6.76 billion. The benefit expense ratio rose 50 basis points to 82.0%, primarily due to higher medical costs in professional and outpatient services, partially offset by favorable prior-year reserve development in 2003.
- Liquidity: Cash and cash equivalents more than doubled to $1.09 billion. Operating cash flow decreased by $121.1 million compared to the prior year, largely due to higher income tax payments and long-term compensation payouts in Q2 2004.
Guidance, Outlook, and Risks
- WellPoint Merger: The most significant corporate event is the pending merger with WellPoint Health Networks Inc., valued at approximately $16.4 billion. While regulatory approvals were obtained from most agencies, the California Department of Insurance disapproved the merger on July 23, 2004. Anthem filed a Writ of Mandate in California Superior Court, and the closing date remains uncertain. Anthem has capitalized $15.9 million in transaction costs.
- Cost of Care Outlook: Management expects aggregate cost of care trends to range from 9.5% to 10.5% for 2004, an increase from 9% in 2003, driven by rising pharmacy costs and unit price increases.
- Capital Allocation: Anthem suspended its stock repurchase program during the merger review period but resumed repurchases in Q3 2004. The company plans to issue up to $2.0 billion in debt securities to fund the WellPoint transaction.
- Legal and Regulatory Risks: The company faces numerous class-action lawsuits regarding provider reimbursement practices (e.g., "down-coding" claims) and government investigations into Medicare fiscal intermediary operations. Management believes these will not have a material adverse effect on financial position.
Investor Verification Checklist
- Merger Status: Verify the current status of the California Department of Insurance appeal and the likelihood of closing the WellPoint transaction.
- Medical Cost Trends: Monitor the 9.5%–10.5% cost of care trend guidance against actual quarterly results, specifically regarding pharmacy and outpatient costs.
- Reserve Development: Review future quarters for "prior year reserve development" adjustments, which significantly impacted 2003 comparables and could affect future earnings volatility.
- Investment Portfolio: Assess the impact of interest rate changes on the $6.4 billion investment portfolio and the potential for other-than-temporary impairments.
- Regulatory Compliance: Track outcomes of ongoing government audits regarding Medicare Part A and Part B operations and provider reimbursement litigation.